Christopher M. Hull, MD

Journal Article

1. Tristani-Firouzi B, Herron ED, Hull CM, Herron MD (2024). Two Techniques to Avoid Cyst Spray During Excision. Cutis, 114(1), 11-26. (Read full article)
2. Herron ED, Snyder AM, Hull CM, LoBello S, Herron MD (2024). Fragile hands: targeting nonmelanoma skin cancer on older hands using 595 nm pulsed dye laser. Lasers Med Sci, 39(1), 101. (Read full article)
3. Kern JA, Amanullah AA, Sahni DR, Mathis JG, Hull CM, Powell DL, Secrest AM (2023). Granulomatous cheilitis - is there a role for allergen screening and avoidance? J Dermatolog Treat, 34(1), 2171707. (Read full article)
4. Hopkins ZH, Jimenez A, Taliercio VL, Clarke JT, Hansen CB, Hull CM, Rhoads JLW, Zone JJ, Sahni VN, Kean J, Secrest AM (2023). Skin-Related Quality of Life During Autoimmune Bullous Disease Course. JAMA Dermatol, 159(11), 1185-1194. (Read full article)
5. Marcacci E, Truong A, Wu C, Presson AP, Lewis BKH, Hull CM (2023). Improving access to dermatologic care: A retrospective analysis of dermatology rural outreach clinics in Utah and Wyoming compared to an urban academic center. J Am Acad Dermatol. (Read full article)
6. Hoshina Y, Wong KH, Galli J, Bacharach R, Klein J, Lebiedz-Odrobina D, Rose JW, Trump B, Hull C, Greenlee JE, Clardy SL (2023). Neurologic involvement in seronegative primary Sjögren's syndrome with positive minor salivary gland biopsy: a single-center experience. Front Neurol, 14, 1174116. (Read full article)
7. Sahni D, Hull C, Grant GJ, Florell S, Wada D, Bowen A, Florell A (2022). An atypical case of eosinophilic pustular folliculitis with associated secondary follicular mucinosis treated with indomethacin. JAAD Case Rep.
8. Amanullah AA, Sahni DR, Sahni VN, Hull CM, Powell DL, Secrest AM (2022). Reply to: current treatment modalities in granulomatous cheilitis. Int J Dermatol. (Read full article)
9. Freeman C, Hull C, Sontheimer R, Curtis J (2020). Squamous cell carcinoma of the dorsal hands and feet after repeated exposure to ultraviolet nail lamps. Dermatol Online J, 26(3). (Read full article)
10. Topham C, Haynes D, Frigerio A, Hull C (2019). Linear amyopathic dermatomyositis with calcinosis cutis responsive to topical sodium thiosulfate. Pediatr Dermatol, 36(4), e102-e103. (Read full article)
11. Varedi D, Frigerio A, Scaife C, Hull C (2019). A novel case of TIF1 gamma autoantibody positive dermatomyositis associated with a non-functional pancreatic neuroendocrine tumor. Dermatol Online J, 25(3). (Read full article)
12. Hull CM, Levin MJ, Tyring SK, Spruance SL (2013). Novel composite efficacy measure to demonstrate the rationale and efficacy of combination antiviral-anti-inflammatory treatment for recurrent herpes simplex labialis. Antimicrob Agents Chemother, 58(3), 1273-8. (Read full article)
13. McCaughey C, Machan M, Bennett R, Zone JJ, Hull CM (2011). Pimecrolimus 1% cream for oral erosive lichen planus: a 6-week randomized, double-blind, vehicle-controlled study with a 6-week open-label extension to assess efficacy and safety. J Eur Acad Dermatol Venereol, 25(9), 1061-7. (Read full article)
14. Hull CM, Harmenberg J, Arlander E, Aoki F, Bring J, Darpo B, Levin MJ, Tyring S, Spruance SL (2011). Early treatment of cold sores with topical ME-609 decreases the frequency of ulcerative lesions: a randomized, double-blind, placebo-controlled, patient-initiated clinical trial. J Am Acad Dermatol, 64(4), 696.e1-11. (Read full article)
15. Hull CM, Brunton S (2010). The role of topical 5% acyclovir and 1% hydrocortisone cream (Xerese™) in the treatment of recurrent herpes simplex labialis. Postgrad Med, 122(5), 1-6. (Read full article)
16. Hull C, Spruance S (2007). Situational antiviral drug prophylaxis for HSV type 1 recurrences. Herpes, 14(2), 37-40. (Read full article)
17. Zone JJ, Taylor T, Hull C, Schmidt L, Meyer L (2007). IgE basement membrane zone antibodies induce eosinophil infiltration and histological blisters in engrafted human skin on SCID mice. J Invest Dermatol, 127(5), 1167-74. (Read full article)
18. Liddle M, Hull C, Liu C, Powell D (2006). Contact urticaria from curcumin. Dermatitis, 17(4), 196-7. (Read full article)
19. Hull C, Spruance S, Tyring S, Hamed K (2006). Single-dose famciclovir for the treatment of herpes labialis. Curr Med Res Opin, 22(9), 1699-702. (Read full article)
20. Hanson N, Hull C, Meyer L (2004). Fever and lymphadenopathy in a farmer. Arch Dermatol, 140(12), 1531-6. (Read full article)
21. Hull C, Larson A, Leachman S (2003). Pharmacogenetic candidate genes for melanoma. Pharmacogenomics, 4(6), 753-65. (Read full article)

Review

1. Nguyen C, Kuceki G, Birdsall M, Sahni DR, Sahni VN, Hull CM (2024). Rosacea: Practical Guidance and Challenges for Clinical Management. [Review]. Clin Cosmet Investig Dermatol, 17, 175-190. (Read full article)
2. Hull CM, Brunton S (2010). The Role of Topical 5% Acyclovir and 1% Hydrocortisone Cream (XereseTM) in the Treatment of Recurrent Herpes Simplex Labialis. [Review]. Postgrad Med, 122(5), 1-6.

Book Chapter

1. Hull C, Zone JJ (Published). Dermatitis herpetiformis and linear IgA bullous dermatosis. In Bolgnia J, Jorizzo (Eds.), Dermatology (3). Elsevier Mosby.

Case Report

1. Jimenez A, Topham C, Varedi D, Leiferman KM, Hull C (2021). Mucosal linear IgA disease with esophageal involvement responsive to ustekinumab. JAAD Case Rep, 15, 4-6. (Read full article)
2. Jimenez A, Hull C, Zone J (2021). Rituximab therapy for a severe case of pretibial myxedema. JAAD Case Rep, 10, 28-30. (Read full article)
3. Abbott J, Kowalski EH, Klein S, DeShazo R, Hull CM (2020). Iatrogenic calcinosis cutis secondary to calcium chloride successfully treated with topical sodium thiosulfate. JAAD Case Rep, 6(3), 181-183. (Read full article)
4. Jimenez A, Hull C, Zone J (2019). Dermatitis herpetiformis resistant to dapsone due to dietary iodide ingestion. JAAD Case Rep, 5(8), 713-714. (Read full article)

Letter

1. Ali NS, Sahni VN, Ma BC, Sahni DR, Hull CM, Powell DL, Secrest AM (2021). Reply to: low response of granulomatous cheilitis to currently established treatments. [Letter to the editor]. J Eur Acad Dermatol Venereol, 35(12), e930-e931. (Read full article)
2. Westerdahl S, Hull CM, Clarke JT, Hansen CB, Rhoads JLW (2020). A single-center, retrospective record review of malignancy prevalence in patients with dermatomyositis with anti-transcription intermediary factor 1γ antibodies via line immunoassay versus immunoprecipitation. [Letter to the editor]. J Am Acad Dermatol, 84(2), 559-561. (Read full article)
3. Truong A, Laggis CW, Annis TD, Secrest AM, Fino NF, Powell DL, Gardner LJ, Gregory T, Hull CM, Lewis BKH (2019). Factors associated with follow-up adherence in patients seen at a referral-based dermatology clinic for the homeless. [Letter to the editor]. J Am Acad Dermatol, 83(2), 629-631. (Read full article)
4. Harris K, Vanderhooft L, Burt L, Vanderhooft S, Hull C (2011). Tanning business practices in Salt Lake County, Utah. [Letter to the editor]. J Am Acad Dermatol, 66(3), 513-4. (Read full article)

News

• Herpes: The Blistering Facts

Podcasts

• Best Ways to Treat a Nail Fungus